April 2026
1. ARBEL R, Rokach L, Razi T, Tadmor T, et al
   Validation of "SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade" in an independent cohort of 4,407 patients.
   Cancer Lett. 2026;643:218319.
   

   >> Share

   
   March 2026
2. WU P, Ge J, Hou X, Qu H, et al
   A circRNA neoantigen vaccine elicits potent antitumor immunity and synergizes with checkpoint blockade in melanoma.
   Cancer Lett. 2026;648:218459.
   

   >> Share

   
   
3. GEORGES-CALDERON N, Fuentes C, Hidalgo Y, Grunenwald F, et al
   Melanoma cells release dysfunctional mitochondria to the tumor microenvironment and circulation in association with tumor progression.
   Cancer Lett. 2026;647:218457.
   

   >> Share

   
   
4. RUMNIEKS F, Vainshelbaum NM, Salmina K, Lazovska M, et al
   Resistance of BRAF(V600E)-mutant melanoma to Vemurafenib: a senescence-induced swing from differentiation to blastulation followed by proliferation.
   Cancer Lett. 2026 Mar 12:218430. doi: 10.1016/j.canlet.2026.218430.
   

   >> Share

   
   February 2026
5. XU S, Huang Z, Li Y, Lu L, et al
   Emerging biomarkers in melanoma: Bridging molecular discovery and precision oncology.
   Cancer Lett. 2026 Feb 22:218359. doi: 10.1016/j.canlet.2026.218359.
   

   >> Share

   
   
6. FU Y, Jiang C, Chen Y, Li F, et al
   Pharmacological inhibition of histone deacetylase 6 and DNA damage repair enhances radiosensitivity in melanoma.
   Cancer Lett. 2026 Feb 17:218322. doi: 10.1016/j.canlet.2026.218322.
   

   >> Share

   
   November 2025
7. GENG D, Chen J, Sanchez A, Davalos SA, et al
   Melanoma Leverages Innate Immune IRAK-M Signaling to Limit Metastasis Through PTPN22-Induced Signaling Repression.
   Cancer Lett. 2025 Nov 27:218172. doi: 10.1016/j.canlet.2025.218172.
   

   >> Share

   
   October 2025
8. WANG C, Han L, Zhang J, Ji Q, et al
   Radiotherapy in combination with PD-1 and TIGIT blockade mediate antitumor abscopal effects and immune memory via CD8(+) T cells.
   Cancer Lett. 2025;631:217935.
   

   >> Share

   
   September 2025
9. MURR N, Richter C, Gupta SK, Hammer E, et al
   TAp73alpha drives cancer metastasis via PPI-mediated derepression of the neuronal HDAC2/REST-GABBR2 axis.
   Cancer Lett. 2025;628:217867.
   

   >> Share

   
   
10. CHEN Y, Wang X, Li H, Zhang Z, et al
    Oncoprotein SND1-enriched exosomes facilitate melanoma lung metastasis by regulating CD47-SIRPalpha-mediated macrophage reprogramming.
    Cancer Lett. 2025 Sep 25:218037. doi: 10.1016/j.canlet.2025.218037.
    

    >> Share

    
    July 2025
11. WOHLFEIL SA, Weller C, Dietsch B, Agardy DA, et al
    Neoadjuvant immune checkpoint inhibition improves protection against hepatic melanoma metastasis.
    Cancer Lett. 2025 Jul 24:217950. doi: 10.1016/j.canlet.2025.217950.
    

    >> Share

    
    June 2025
12. WANG W, Yang H, Passang T, Li Y, et al
    Targeting the VIP-VPAC Pathway in Melanoma Models Inhibits Tumor Growth and Liver Metastasis.
    Cancer Lett. 2025 Jun 5:217855. doi: 10.1016/j.canlet.2025.217855.
    

    >> Share

    
    April 2025
13. TANG R, Xu X, Yang W, Yu W, et al
    Corrigendum to "MED27 promotes melanoma growth by targeting AKT/MAPK and NF/kappaB/iNOS signaling pathway" [Cancer Lett. 373(1) (2016) 77-87 PMID 26797421].
    Cancer Lett. 2025;623:217717.
    

    >> Share

    
    
14. TIAN H, Chen Y, Dong X, Fan X, et al
    The m(6)A hypermethylation-induced PIR overexpression regulates H3K4me3 and promotes Tumorigenesis of Uveal Melanoma.
    Cancer Lett. 2025 Apr 17:217729. doi: 10.1016/j.canlet.2025.217729.
    

    >> Share

    
    March 2025
15. HOSSAIN SM, Gimenez G, Stockwell P, Weeks R, et al
    Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapy.
    Cancer Lett. 2025 Mar 13:217638. doi: 10.1016/j.canlet.2025.217638.
    

    >> Share

    
    
16. UHER O, Hadrava Vanova K, Labitt R, Petrlakova K, et al
    Neoadjuvant intratumoral MBT(A) immunotherapy prevents distant metastases and recurrence in murine models.
    Cancer Lett. 2025;612:217464.
    

    >> Share

    
    February 2025
17. MARRANCI A, Maresca L, Lodovichi S, Luserna di Rora AG, et al
    PARP1 in Melanoma: Mechanistic Insights and Implications for Basic and Clinical Research.
    Cancer Lett. 2025 Feb 28:217599. doi: 10.1016/j.canlet.2025.217599.
    

    >> Share

    
    
18. URZI O, Olofsson Bagge R, Crescitelli R
    Extracellular vesicles in uveal melanoma - biological roles and diagnostic value.
    Cancer Lett. 2025 Feb 4:217531. doi: 10.1016/j.canlet.2025.217531.
    

    >> Share

    
    December 2024
19. VAN TRIMPONT M, Schalk AM, Hofkens K, Peeters E, et al
    A human-like glutaminase-free asparaginase is highly efficacious in ASNS(low) leukemia and solid cancer mouse xenograft models.
    Cancer Lett. 2024 Dec 19:217404. doi: 10.1016/j.canlet.2024.217404.
    

    >> Share

    
    November 2024
20. TRAPPETTI V, Fernandez-Palomo C, Arora P, Potez M, et al
    "Towards melanoma in situ vaccination with multiple ultra-narrow X-ray beams".
    Cancer Lett. 2024 Nov 13:217326. doi: 10.1016/j.canlet.2024.217326.
    

    >> Share

    
    August 2024
21. GAO Q, Li N, Pan Y, Chu P, et al
    Hepatocyte growth factor promotes melanoma metastasis through ubiquitin-specific peptidase 22-mediated integrins upregulation.
    Cancer Lett. 2024 Aug 31:217196. doi: 10.1016/j.canlet.2024.217196.
    

    >> Share

    
    
22. FLETCHER K, Cortellini A, Ganta T, Kankaria R, et al
    Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study.
    Cancer Lett. 2024;596:217001.
    

    >> Share

    
    
23. KIM YJ, Lee M, Kim EH, Lee S, et al
    Real-world incidences and risk factors of immune-related adverse events in patients treated with immune checkpoint inhibitors: A nationwide retrospective cohort study.
    Cancer Lett. 2024;596:216998.
    

    >> Share

    
    July 2024
24. LIU M, Zhao Z, Wang C, Sang S, et al
    Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells.
    Cancer Lett. 2024;594:216991.
    

    >> Share

    
    
25. FU Z, Zhang L, Chen R, Zhan J, et al
    Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial cells in guidance of specifying the field cancerized surgical excision margin and administering immunotherapy.
    Cancer Lett. 2024;598:217099.
    

    >> Share

    
    June 2024
26. ZHANG X, Cui X, Li P, Zhao Y, et al
    EGC enhances tumor antigen presentation and CD8(+) T cell-mediated antitumor immunity via targeting oncoprotein SND1.
    Cancer Lett. 2024;592:216934.
    

    >> Share

    
    
27. LIAO Q, Shi H, Yang J, Ge S, et al
    FTO elicits tumor neovascularization in cancer-associated fibroblasts through eliminating m(6)A modifications of multiple pro-angiogenic factors.
    Cancer Lett. 2024;592:216911.
    

    >> Share

    
    May 2024
28. WANG J, Hirose H, Du G, Chong K, et al
    Corrigendum to "P-REX1 amplification promotes progression of cutaneous melanomavia the PAK1/P38/MMP-2 pathway" [Cancer Lett. 407 (2017) 66-75].
    Cancer Lett. 2024 May 23:216966. doi: 10.1016/j.canlet.2024.216966.
    

    >> Share

    
    April 2024
29. JIA Y, Zhang F, Meng X, Andreev D, et al
    Osteocytes support bone metastasis of melanoma cells by CXCL5.
    Cancer Lett. 2024 Apr 6:216866. doi: 10.1016/j.canlet.2024.216866.
    

    >> Share

    
    
30. WANG L, Liu X, Han Y, Tsai HI, et al
    TRAF6 enhances PD-L1 expression through YAP1-TFCP2 signaling in melanoma.
    Cancer Lett. 2024 Apr 5:216861. doi: 10.1016/j.canlet.2024.216861.
    

    >> Share

    
    February 2024
31. MIRZAEI H, Salehi H, Oskuee RK, Mohammadpour A, et al
    Retraction notice to "The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model" [Cancer Lett. 419 (2018) 30-39].
    Cancer Lett. 2024 Feb 2:216670. doi: 10.1016/j.canlet.2024.216670.
    

    >> Share

    
    January 2024
32. ZHANG J, Joshua AM, Yue L, O'Meara CH, et al
    Targeted therapy, immunotherapy, and small molecules and peptidomimetics as emerging immunoregulatory agents for melanoma.
    Cancer Lett. 2024 Jan 26:216633. doi: 10.1016/j.canlet.2024.216633.
    

    >> Share

    
    
33. LIU C, Cheng X, Han K, Hong L, et al
    A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
    Cancer Lett. 2024 Jan 19:216663. doi: 10.1016/j.canlet.2024.216663.
    

    >> Share

    
    November 2023
34. CERDIDO S, Abrisqueta M, Sanchez-Beltran J, Lambertos A, et al
    MGRN1 depletion promotes intercellular adhesion in melanoma by upregulation of E-cadherin and inhibition of CDC42.
    Cancer Lett. 2023;581:216484.
    

    >> Share

    
    
35. HU X, Hu Z, Zhang H, Zhang N, et al
    Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses.
    Cancer Lett. 2023 Nov 7:216466. doi: 10.1016/j.canlet.2023.216466.
    

    >> Share

    
    September 2023
36. XU M, Li S
    Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment.
    Cancer Lett. 2023 Sep 18:216397. doi: 10.1016/j.canlet.2023.216397.
    

    >> Share

    
    July 2023
37. ZHANG X, Hu Z, Wang X, Li L, et al
    Corrigendum to "ANXA10 promotes melanoma metastasis by suppressing E3 ligase TRIM41-directed PKD1 degradation" [Cancer Lett. 519 (2021) 237-249].
    Cancer Lett. 2023 Jul 18:216310. doi: 10.1016/j.canlet.2023.216310.
    

    >> Share

    
    April 2023
38. ZHAN D, Zheng N, Zhao B, Cheng F, et al
    Expanding individualized therapeutic options via genoproteomics.
    Cancer Lett. 2023;560:216123.
    

    >> Share

    
    March 2023
39. ZHAO J, Gao N, Xu J, Zhu X, et al
    Novel strategies in melanoma treatment using silver nanoparticles.
    Cancer Lett. 2023 Mar 27:216148. doi: 10.1016/j.canlet.2023.216148.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share